Costimulatory pathway targets for autoimmune and inflammatory conditions: clinical successes, failures, and hope for the future-Reference-Cited by-同舟云学术

Costimulatory pathway targets for autoimmune and inflammatory conditions: clinical successes, failures, and hope for the future

Published:2019-01-11 Issue:2 Volume:28 Page:99-106
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Spicer Pamela¹^ORCID,Runkel Laura¹

Affiliation:

1. Informa Pharma Intelligence, New York, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1557146

Reference51 articles.

1. Costimulatory Pathways in Kidney Transplantation: Pathogenetic Role, Clinical Significance and New Therapeutic Opportunities

2. CD28 and ICOS: Similar or separate costimulators of T cells?

3. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade

4. Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders

5. Trialtrove® database [Internet]. Informa Pharma Intelligence, Citeline; [cited 2018 Nov 30]. Available from: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/trialtrove . Access to Trialtrove® is provided via company-specific URLs, and users are granted access via IP recognition.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure;Nature Reviews Cardiology;2024-01-26

2. Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind , Placebo‐Controlled , Multiple Ascending Dose Study;ACR Open Rheumatology;2022-07-27

3. Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression;Clinical and Experimental Immunology;2021-09-22

4. Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF;Cardiovascular Research;2021-07-15

5. Anti-C5 Antibody Tesidolumab Reduces Early Antibody-mediated Rejection and Prolongs Survival in Renal Xenotransplantation;Annals of Surgery;2021-07-07